NK function and clinical trastuzumab activity in metastatic breast cancer patients

被引：0
|
作者：
Beano, A.
Signorino, E.
MA, Polimeni
Mistrangelo, M.
Spadi, R.
AM, Vandone
Donadio, M.
Matera, P.
Lista, I
Facilissimo, R.
Napolitano, L.
机构：
[1] Osped San Giovana Battista, UOA Oncol Med, Turin, Italy
[2] Univ Turin, Dipartimento Med Interna, Lab Immunol Tumori, I-10124 Turin, Italy
来源：
ANNALS OF ONCOLOGY | 2007年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：38 / 38
页数：1
相关论文
共 50 条
  • [21] Are there benefits in routine clinical practice of continuing trastuzumab after progression for metastatic breast cancer patients?
    Esposito, Angela
    Munzone, Elisabetta
    Bagnardi, Vincenzo
    Adamoli, Laura
    Sciandivasci, Angela
    Cullura, Daniela
    Goldhirsch, Aron
    Nole, Franco
    ANTI-CANCER DRUGS, 2012, 23 (10) : 1089 - 1098
  • [22] Retreatment with trastuzumab in Her2-positive metastatic breast cancer patients: a clinical study
    F Carabantes-Ocón
    E Saez-Lara
    L Burgos-Garcia
    E Villar-Chamorro
    A Casaus-Hazañas
    S Luna
    C Martínez
    Breast Cancer Research, 9
  • [23] Survival in patients with non-metastatic breast cancer treated with adjuvant trastuzumab in clinical practice
    Gallagher, Christopher M.
    More, Kenneth
    Masaquel, Anthony
    Kamath, Tripthi
    Guerin, Annie
    Ionescu-Ittu, Raluca
    Nitulescu, Roy
    Gauthier-Loiselle, Marjolaine
    Sicignano, Nicholas
    Butts, Elizabeth
    Wu, Eric Q.
    Barnett, Brian
    SPRINGERPLUS, 2016, 5
  • [24] Neuregulin (NRG) expression modulates clinical response to trastuzumab in patients with metastatic breast cancer (MBC).
    De Alava, E.
    Abad, M.
    Rodriguez, C. A.
    Montero, J. C.
    Serrano, E.
    Ocana, A.
    Torres, A.
    Ruiz, M.
    Cruz, J. J.
    Pandiella, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 557S - 557S
  • [25] Retreatment with trastuzumab in Her2-positive metastatic breast cancer patients:: a clinical study
    Carabantes-Ocon, F.
    Saez-Lara, E.
    Burgos-Garcia, L.
    Villar-Chamorro, E.
    Casaus-Hazanas, A.
    Luna, S.
    Martinez, C.
    BREAST CANCER RESEARCH, 2007, 9 (01)
  • [26] Trastuzumab (herceptin™) monotherapy in patients with pretreated metastatic breast cancer.
    Eidtmann, H
    Clemens, M
    von Minckwitz, G
    Nitz, U
    Marme, A
    Niederle, N
    du Bois, A
    Habicht, A
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 303 - 303
  • [27] Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer
    Clayton, AJ
    Danson, S
    Jolly, S
    Ryder, WDJ
    Burt, PA
    Stewart, AL
    Wilkinson, PM
    Welch, RS
    Magee, B
    Wilson, G
    Howell, A
    Wardley, AM
    BRITISH JOURNAL OF CANCER, 2004, 91 (04) : 639 - 643
  • [28] Optimizing clinical care of patients with metastatic breast cancer:: a new oral vinorelbine plus trastuzumab combination
    Catania, C.
    Medici, M.
    Magni, E.
    Munzone, E.
    Cardinale, D.
    Adamoli, L.
    Sanna, G.
    Minchella, I.
    Radice, D.
    Goldhirsch, A.
    Nole, F.
    ANNALS OF ONCOLOGY, 2007, 18 (12) : 1969 - 1975
  • [29] Trastuzumab Combined with Pegylated Liposomal Doxorubicin in Patients with Metastatic Breast Cancer
    Christodoulou, Christos
    Kostopoulos, Ioannis
    Kalofonos, Haralabos P.
    Lianos, Evangelos
    Bobos, Mattheos
    Briasoulis, Evangelos
    Gogas, Helen
    Razis, Evangelia
    Skarlos, Dimosthenis V.
    Fountzilas, George
    ONCOLOGY, 2009, 76 (04) : 275 - 285
  • [30] Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer
    A J Clayton
    S Danson
    S Jolly
    W D J Ryder
    P A Burt
    A L Stewart
    P M Wilkinson
    R S Welch
    B Magee
    G Wilson
    A Howell
    A M Wardley
    British Journal of Cancer, 2004, 91 : 639 - 643
12345